Noel Barrett
Vaccines
Baxter
Malaysia
Biography
Noel Barrett has played a lead role in Baxter’s vaccines business since joining the company as part of the acquisition of Immuno AG in 1997. He led the reformulation and licensure of Baxter’s FSME tick-borne encephalitis vaccine in Europe, and more recently the licensure of Baxter’s H5N1 influenza vaccine. He also helped develop viral-inactivation technologies for plasma products in the late 1980s and early 1990s, when the risk of transmitting viral pathogens through such products was a life-threatening concern for patients.
Research Interest
Vaccines, viral-inactivation technologies for plasma products
